Search

A recent study conducted at Jinan Stomatological Hospital focused on primary epithelial-myoepithelial carcinoma of the salivary gland (EMC-SG). The research aimed to assess the clinical characteristics, prognosis, and survival factors associated with EMC-SG. The study found that EMC-SG patients generally have a less aggressive course and favorable prognosis, with established nomograms providing a useful tool for predicting patient outcomes. This research contributes valuable insights into a rare disease, offering clinicians a customized approach to counseling patients. [Extracted from the article]

A new study from Zunyi Medical University in Guizhou, China, focuses on epithelial-myoepithelial carcinoma (EMC), a rare tumor that typically occurs in the major salivary glands but is rarely reported in the nasal cavity. The study examines a case of EMC originating from a minor salivary gland in the inferior turbinate of a 48-year-old woman. The patient recovered well after surgery, and the study also discusses the clinical presentation, treatment, and prognosis of EMC in the nasal cavity and paranasal sinuses. This research provides valuable insights into a rare form of cancer. [Extracted from the article]

A recent report from researchers at University Hospital in Naples, Italy discusses the rare neoplasm known as epithelial myoepithelial carcinoma (EMC). This type of cancer affects the salivary glands, particularly the parotid gland, and is characterized by a biphasic tubular structure. The patient in the case study had a good prognosis and achieved complete treatment-response. However, further research and long-term follow-up data are needed to better understand the pathophysiology and prognosis of EMC. The full report can be accessed in the journal Oral and Maxillofacial Surgery Cases. [Extracted from the article]

A recent systematic review conducted by researchers at the University of Otago in Wellington, New Zealand, examined the presenting characteristics and treatment outcomes of epithelial-myoepithelial carcinoma (EMC), a rare salivary gland malignancy. The review included 91 cases of EMC from 57 studies and found that surgery with clear margins is the mainstay of treatment for EMC in the head and neck region. The study also found that adjuvant radiotherapy may decrease the risk of local disease recurrence and improve disease-free survival in certain cases. The research provides evidence-based guidance for the management of EMC. [Extracted from the article]

Researchers at Adichunchanagiri University have conducted a study on epithelial myoepithelial carcinoma, a type of cancer. The study focuses on hybrid tumors, which are defined as two or more neoplasms occurring in one organ. The researchers found that hybrid tumors in the parotid gland, a salivary gland, are rare but pose a challenge for cytopathologists. They reported a case of a hybrid tumor in the parotid gland that was initially misinterpreted as a different type of cancer. This research provides valuable insights into the cytology of epithelial myoepithelial carcinoma and Warthin's tumor. [Extracted from the article]

Cancer, Carcinomas, Epithelial Myoepithelial Carcinoma, Health and Medicine, Oncology Keywords: Cancer; Carcinomas; Epithelial Myoepithelial Carcinoma; Health and Medicine; Oncology EN Cancer Carcinomas Epithelial Myoepithelial Carcinoma Health and Medicine Oncology 179 179 1 08/14/23 20230815 NES 230815 2023 AUG 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New study results on epithelial myoepithelial carcinoma have been published. [Extracted from the article]